Edition:
United States

West Pharmaceutical Services Inc (WST)

WST on New York Consolidated

83.22USD
7 Dec 2016
Change (% chg)

$-0.17 (-0.20%)
Prev Close
$83.39
Open
$83.23
Day's High
$83.52
Day's Low
$82.25
Volume
92,398
Avg. Vol
374,157
52-wk High
$84.33
52-wk Low
$53.88

Summary

Name Age Since Current Position

Patrick Zenner

68 2015 Non-Executive Chairman of the Board

Eric Green

46 2015 President, Chief Executive Officer, Director

William Federici

56 2013 Chief Financial Officer, Senior Vice President

Warwick Bedwell

56 2011 President - Pharmaceutical Packaging Systems Asia Pacific Region

Heino Lennartz

50 2010 President - Pharmaceutical Packaging Systems Europe Region

Christopher Ryan

55 2015 President - Pharmaceutical Packaging Systems Americas Region

Annette Favorite

51 2015 Chief Human Resource Officer, Senior Vice President

George Miller

61 2015 Senior Vice President, General Counsel, Corporate Secretary

Karen Flynn

53 2016 Senior Vice President and Chief Commercial Officer

David Montecalvo

51 2016 Senior Vice President - Global Operations and Supply Chain

Eric Resnick

2016 Chief Technology Officer, Vice President

Daniel Malone

54 2011 Vice President, Corporate Controller

Michael Anderson

60 2001 Vice President, Treasurer

Quintin Lai

2016 Vice President - Corporate Development, Strategy and Investor Relations

Paolo Pucci

55 2016 Director

Mark Buthman

55 2011 Independent Director

William Feehery

44 2012 Independent Director

Thomas Hofmann

64 2007 Independent Director

Paula Johnson

55 2005 Independent Director

Myla Lai-Goldman

57 2014 Independent Director

Douglas Michels

58 2011 Independent Director

John Weiland

60 2007 Independent Director

Biographies

Name Description

Patrick Zenner

Mr. Patrick J. Zenner is Non-Executive Chairman of the Board of West Pharmaceutical Services, Inc., Mr. Zenner is retired from Hoffmann-La Roche Inc., North America, the prescription drug unit of the Roche Group, a leading research-based healthcare enterprise, where he served as President and Chief Executive Officer from 1993 to January 2001. He was a director and the Chairman of the Board of Exact Sciences Corporation until July 2010, and from July 2007 until March 2008, served as its Interim CEO. He also served as Interim Chief Executive Officer of CuraGen Corporation from May 2005 through March 2006. In addition, Mr. Zenner serves as Chairman of the Board and a director of ArQule, Inc. He previously served as director of Xoma Corporation from 2002 to 2010 and Par Pharmaceuticals from 2009 to 2012. Mr. Zenner provides to the Board over 40 years of experience and expertise in the pharmaceutical industry. Since retiring from Hoffmann-La Roche, Mr. Zenner has devoted his considerable industry expertise and corporate-governance knowledge to small and early-stage pharmaceutical and technology companies in various capacities, including board member, chairman and interim CEO.

Eric Green

Mr. Eric Mark Green is President, Chief Executive Officer, Director of the Company. Prior to joining West, he was Executive Vice President and President of the Research Markets business unit at Sigma-Aldrich Corporation, a leading life science and technology company, from 2013 to 2015. From 2009 to 2013, he served as Vice President and Managing Director, International, where he was responsible for Asia Pacific and Latin America, and prior thereto, held various commercial and operational roles.

William Federici

Mr. William J. Federici is Senior Vice President, and Chief Financial Officer of the company since joining the Company in August 2003. He was National Industry Director for Pharmaceuticals of KPMG LLP (accounting firm) from June 2002 until August 2003 and, prior thereto, an audit partner with Arthur Andersen, LLP.

Warwick Bedwell

Mr. Warwick Bedwell is President of Pharmaceutical Packaging Systems Asia Pacific Region since January 3, 2011. Previously, he served as Vice President and Commercial Director-Bone and Rheumatology for Roche Products (UK) Limited, a biotech company, from October 2008 to August 2010. From January 2007 to October 2008, he served as Vice President and Global Head of Business Development for Hoffman LaRoche Inc. (U.S.) and from June 2003 to December 2006, he served as President and General Manager of Roche Inc. in the Philippines. Prior thereto, he held numerous positions in commercial operations for Roche Products Pty Ltd. in Australia.

Heino Lennartz

Mr. Heino Lennartz is President -Pharmaceutical Packaging Systems Europe Region since February 2010. Prior to that, he was President, Europe, Pharmaceutical Systems since July 2009. He was Vice President Finance, MIS & Purchasing for Europe & Asia Pacific from December 2006 until July 2009. Mr. Lennartz was Vice President Corporate Finance of AIXTRON AG, a leading semiconductor equipment company, from 2003 to 2006 and, prior thereto, held various positions, including Director Business Systems Europe, at GDX Automotive, a rubber and plastic car body sealing system supplier.

Christopher Ryan

Mr. Christopher G. Ryan is President - Pharmaceutical Packaging Systems Americas Region since February 2015. Previously, he served as Global Business Leader and Strategic Marketer for the Industrial Product Division at W.L. Gore. Prior to serving in this role, he led a Global Consumer Performance Fabric Business Unit at the same company. Prior thereto, he held various senior positions at Cargill, Inc.

Annette Favorite

Ms. Annette Favorite is Senior Vice President and Chief Human Resources Officer of West Pharmaceutical Services, Inc., effective October 5, 2015. Prior to joining West, she spent more than 25 years at IBM Corporation, an information technology services company, in a number of strategic and global human resources roles. Most recently, she served as Vice President, Global Talent Management.

George Miller

Mr. George Lloyd Miller, J.D. is Senior Vice President, General Counsel, Corporate Secretary of West Pharmaceutical Services, Inc. Previously, he served as Senior Vice President, General Counsel and Corporate Secretary for Sigma-Aldrich Corporation from 2009 to 2015. Prior to working at Sigma-Aldrich, he held senior legal positions with Novartis AG, a global healthcare company.

Karen Flynn

Ms. Karen A. Flynn is Senior Vice President and Chief Commercial Officer of the Company. She was President - Pharmaceutical Packaging Systems since October 2014. She was President, Pharmaceutical Packaging Systems Americas Region from June 2012 to October 2014 and served as Vice President, Sales from May 2008 to June 2012. From 2000 to 2008, she worked in Sales Management, most recently as Vice President, Global Accounts, for Catalent (formerly known as Cardinal Health). Prior thereto, she held various positions at West, including Quality, Research and Development, and Sales.

David Montecalvo

Mr. David A. Montecalvo serves as Senior Vice President - Global Operations and Supply Chain of the Company. Mr. Montecalvo, joins the Company from Medtronic plc, where he served in a number of senior leadership roles, including Vice President, Contract Manufacturing Operations, for the company’s Restorative Therapies Group, a $7 billion group of businesses; and Vice President, Business Operations Integration, where he was responsible for directing and leading the global operations integration of Covidien plc into Medtronic. Prior to working at Medtronic, Mr. Montecalvo held senior operations and product development roles at Urologix, Inc. and LecTec Corporation. Mr. Montecalvo earned a Bachelor of Science degree in biomedical engineering from Case Western Reserve University. He also earned a Master of Business Administration degree in venture management from the University of St. Thomas.

Eric Resnick

Mr. Eric Resnick is Vice President and Chief Technology Officer of the company. effective April 1, 2016. He recently served as Vice President and General Manager of Integrated Packaging and Delivery within the Innovation and Technology Team. SinceJanuary 2010, Mr. Resnick served in various R&D and Engineering executive roles at West, including Vice President R&D and Self-Injection Systems. He also served as Vice President and General Manager of West's Contract Manufacturing Delivery Devices division. Prior to joining West, Mr. Resnick held engineering and operating roles with Eastman Kodak and Ortho Clinical Diagnostics. He is a certified Six Sigma Black Belt with a BS in Plastics Engineering from the University of Massachusetts Lowell and an MBA from the University of Phoenix.

Daniel Malone

Mr. Daniel Malone is Vice President and Corporate Controller of the Company, since August 2011. He was Vice President of Finance, Pharmaceutical Packaging Systems Americas Region from September 2008 to August 2011 and Director of Financial and Management Reporting from October 1999 to September 2008.

Michael Anderson

Mr. Michael A. Anderson is Vice President and Treasurer of the Company, since June 2001. He was Finance Director, Drug Delivery Systems Division from October 1999 to June 2001, Vice President, Business Development from April 1997 to October 1999 and Director of Taxes from July 1992 to April 1997.

Quintin Lai

Dr. Quintin J. Lai Ph.D. is Vice President - Corporate Development, Strategy and Investor Relations of the West Pharmaceutical Services, Inc. Prior to joining West, Dr. Lai served as Vice President of Investor Relations and Corporate Strategy at Sigma-Aldrich Corporation, where he was responsible for developing a global strategy for that S&P 500 company, as well as creating an industry-leading IR function. From 2002-2012, Dr. Lai served as Managing Director and Senior Equity Research analyst of the Life Science Tools and Diagnostic sector at Robert W. Baird & Company. Dr. Lai also spent eight years as a Senior Research Engineer at Atlantic Richfield (ARCO). Dr. Lai received a Ph.D. in Chemical Engineering from the University of Wisconsin-Madison , an MBA from the University of Chicago Booth School of Business and a B.S. in Chemical Engineering from the University of Alabama. He is also a CFA charterholder.

Paolo Pucci

Mr. Paolo Pucci serves as Director of the company,. He is Chief Executive Officer of ArQule, Inc., a biopharmaceutical company engaged in the research and development of targeted therapeutics. Prior to his joining ArQule in 2008, Mr. Pucci worked at Bayer A.G., where he served in a number of leadership capacities including Senior Vice President of the Global Specialty Medicine Business Unit and was a member of the Bayer Pharmaceuticals Global Management Committee.

Mark Buthman

Mr. Mark A. Buthman is an Independent Director of West Pharmaceutical Services, Inc., Mr. Buthman has been Senior Vice President and Chief Financial Officer of Kimberly-Clark Corporation since 2003. He joined Kimberly-Clark in 1982. Mr. Buthman was appointed Vice President of Strategic Planning and Analysis in 1997 and Vice President of Finance in 2002. Mr. Buthman announced his intention to retire from Kimberly-Clark at the end of 2015 and step down as the Chief Financial Officer effective April 27, 2015. Mr. Buthman is also Vice Chairman of the Board of Directors of Pavillon, International and K-C de Mexico S.A., C.V. and a member of the University of Iowa, Tippie College of Business Advisory Board. In addition to his financial and accounting experience as Chief Financial Officer at Kimberly-Clark, a global producer of branded products for the consumer, professional and healthcare markets, Mr. Buthman is responsible for real estate, investor relations, information technology, finance and accounting shared services and global procurement for the corporation. Throughout his tenure at Kimberly-Clark, he has served in a wide range of leadership roles in the areas of analysis, strategy and mergers and acquisitions.

William Feehery

Dr. William F. Feehery, Ph.D. is an Independent Director of West Pharmaceutical Services, Inc., Dr. Feehery has been President of Industrial Biosciences at E. I. du Pont de Nemours and Company since November 2013. He served as Global Business Director, DuPont Photovoltaic Solutions and previously as Global Business Director, Electronics Growth Businesses and as President of DuPont Displays, Inc. He joined DuPont in 2002. Prior to joining DuPont he was engaged in venture capital and was a management consultant for the Boston Consulting Group. Dr. Feehery brings extensive global public company leadership experience to the Board, having served in leadership roles throughout the DuPont organization, a provider of innovative products and services for markets including agriculture, nutrition, electronics, communications, safety and protection, home and construction, transportation and apparel. In addition, Dr. Feehery brings considerable technical experience with a Ph.D. in chemical engineering and over ten years of experience in the technology industry.

Thomas Hofmann

Mr. Thomas W. Hofmann is an Independent Director of West Pharmaceutical Services, Inc., Mr. Hofmann is the retired Senior Vice President and CFO of Sunoco, Inc. (oil refining and marketing company), where he served in that capacity from January 2002 until December 2008. Mr. Hofmann also served Sunoco in various other senior management roles since 1990. Mr. Hofmann provides substantial financial, corporate governance and management experience with expertise in all areas of finance, including tax, accounting, auditing, treasury, investor relations and budgeting, and he is well-versed in strategic planning, risk-management and capital-market issues. During a distinguished career with Sunoco, Inc., Mr. Hofmann was involved in a number of unique transactions, including significant acquisitions and divestitures.

Paula Johnson

Dr. Paula A. Johnson, M.D. is an Independent Director of West Pharmaceutical Services, Inc., Dr. Johnson is a cardiologist and has been the Executive Director of the Connors Center for Women’s Health and Gender Biology and Chief of the Division of Women’s Health at Brigham and Women’s Hospital since January 2002. Dr. Johnson also is a Professor at Harvard Medical School. Dr. Johnson brings a wealth of leading healthcare expertise to our Board. She is a nationally recognized expert in cardiology and women’s and minority healthcare issues. In her role as Executive Director of the Connors Center for Women’s Health and Gender Biology and as Chief of the Division of Women’s Health at Brigham and Women’s Hospital, and a Professor of Epidemiology at the Harvard School of Public Health, Dr. Johnson has built a novel, interdisciplinary research, education, clinical and policy program in women’s health whose mission is to improve the health of women and to transform their medical care. Dr. Johnson has extensive experience in developing quality control systems in health care. Dr. Johnson is the recipient of many awards recognizing her contributions to women’s and minority health and is featured as a national leader in medicine by the National Library of Medicine and has been elected to the Institute of Medicine. She has an extensive background in quality and safety in healthcare and in public health systems.

Myla Lai-Goldman

Dr. Myla P. Lai-Goldman, M.D., is an Independent Director of West Pharmaceutical Services, Inc. Dr. Lai-Goldman is Chief Executive Officer and President of GeneCentric Diagnostics, Inc. (molecular diagnostics company) since June 2011. She also serves as the managing partner of Personalized Science, LLC, a clinical diagnostics consulting company she founded in 2008. Since August 2011, Dr. Lai-Goldman has been a Venture Partner at Hatteras Venture Partners. From June 2009 to December 2010, Dr. Lai-Goldman was Chief Executive Officer and Chief Scientific Officer of CancerGuide Diagnostics, Inc. (genomic-based clinical and pharmaceutical cancer testing and services). Prior to that time, Dr. Lai-Goldman served in various roles at Laboratory Corporation of America Holdings and its predecessor company, Roche Biomedical Laboratories (clinical laboratory company), including Executive Vice President, Chief Medical Officer and Chief Scientific Officer. Dr. Lai-Goldman is a recognized author and speaker on clinical diagnostics.

Douglas Michels

Mr. Douglas A. Michels is an Independent Director of West Pharmaceutical Services, Inc., Mr. Michels serves as President and Chief Executive Officer of OraSure Technologies, Inc. and a member of the OraSure Board of Directors, positions he has held since June 2004. In February 2010, Mr. Michels was appointed to the Presidential Advisory Council on HIV/AIDS. He previously served on the Board of the National Blood Foundation, the Board of the National Committee for Quality Health Care and the Coalition to Protect America’s Health Care. Mr. Michels brings considerable expertise and executive leadership skills in the pharmaceutical, medical device and diagnostic industry having spent ten years with OraSure Technologies, Inc., 19 years with Johnson & Johnson and seven years with Abbott Laboratories.

John Weiland

Mr. John H. Weiland is an Independent Director of West Pharmaceutical Services, Inc., Mr. Weiland has been President and Chief Operating Officer of C. R. Bard, Inc., a medical-device company, since August 2003, and served as its Group President from April 1997 to August 2003 and its Group Vice President from March 1996 to April 1997. Mr. Weiland also serves as a director of C. R. Bard, Inc. In 2012, Mr. Weiland received the prestigious Horatio Alger Award and serves as a director of the Horatio Alger Association. Mr. Weiland has considerable expertise with over 30 years of experience in the healthcare industry and brings to our Board executive leadership in medical-device company operations with significant international business expertise. As Bard’s President and Chief Operating Officer, Mr. Weiland has responsibility for all of its business operations